🇺🇸 FDA
Patent

US 10004687

Liposomal curcumin for treatment of diseases

granted A61KA61K31/12A61K45/06

Quick answer

US patent 10004687 (Liposomal curcumin for treatment of diseases) held by The Board of Regents of the University of Texas System expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/12, A61K45/06, A61K9/1271, A61K9/1272